您的位置: 首页 > 农业专利 > 详情页

ANTICORPS MONOCLONAUX DE CSPG4 UTILISES DANS LE DIAGNOSTIC ET LE TRAITEMENT DU CARCINOME MAMMAIRE DE TYPE BASAL
专利权人:
UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
发明人:
FERRONE, SOLDANO,WANG, XINHUI
申请号:
EP09815308
公开号:
EP2338055A4
申请日:
2009.09.18
申请国别(地区):
EP
年份:
2012
代理人:
摘要:
It is disclosed herein that condroitin sulfate proteoglycan 4 (CSPG4), also known as high molecular weight melanoma associated antigen, is overexpressed on basal breast carcinoma cells (BBC), specifically triple negative basal breast carcinoma cells (TNBC). Methods for detecting basal breast cancer in a subject are disclosed. Methods are also disclosed for inhibiting the growth of a basal breast cancer cell. These methods include contacting the basal breast cancer cell with an effective amount of an antibody that specifically binds CSPG4. Additional treatment methods, and the use of antibody panels, are also described herein.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充